Picture of Cencora logo

COR Cencora Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Annual cashflow statement for Cencora, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line854-3,4001,5451,6671,733
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items595475-95270442
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital3696,269366-140875
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,3442,2072,6652,7023,911
Capital Expenditures-310-370-438-496-458
Purchase of Fixed Assets
Other Investing Cash Flow Items-65.6-10.2-5,703128-2,144
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-376-380-6,142-368-2,602
Financing Cash Flow Items-16.7-33.5-13.7-48.2-80.7
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,087-6041,953-1,753-2,222
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash8821,224-1,528523-841